Boskovic M, Jortveit J, Haraldsen MB, Berge T, Engdahl J, Løchen ML, Schuster P, Sandberg EL, Grimsmo J, Atar D, Anfinsen OG, Pripp AH, Grenne BL, Halvorsen S (2024)
The NORwegian atrial fibrillation self-SCREENing trial (NORSCREEN): Rationale and design of a randomized controlled trial
Europace (in press)
DOI 10.1093/europace/euae228, PubMed 39248170

Pascoe B, Futcher G, Pensar J, Bayliss SC, Mourkas E, Calland JK, Hitchings MD, Joseph LA, Lane CG, Greenlee T, Arning N, Wilson DJ, Jolley KA, Corander J, Maiden MCJ, Parker CT, Cooper KK, Rose EB, Hiett K, Bruce BB, Sheppard SK (2024)
Machine learning to attribute the source of Campylobacter infections in the United States: a retrospective analysis of national surveillance data
J Infect, 106265 (in press)
DOI 10.1016/j.jinf.2024.106265, PubMed 39245152

Belus JM, Johnson NE, Yoon GH, Tschumi N, Lerotholi M, Falgas-Bague I, Lee TT, Letsoela P, Magidson JF, Amstutz A, Labhardt ND (2024)
SMSs as an alternative to provider-delivered care for unhealthy alcohol use: study protocol for Leseli, an open-label randomised controlled trial of mhGAP-Remote vs mhGAP-Standard in Lesotho
Trials, 25 (1), 575
DOI 10.1186/s13063-024-08411-3, PubMed 39223600